- Home
- BAOS vs SLRX Comparison
BAOS vs SLRX Comparison
Compare BAOS & SLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BAOS | SLRX |
|---|---|---|
| Founded | 2018 | N/A |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6M | 3.6M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | BAOS | SLRX |
|---|---|---|
| Price | $2.90 | $0.69 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 65.4K | ★ 511.7K |
| Earning Date | 12-26-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $860,951.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 0.20 | N/A |
| 52 Week Low | $1.44 | $0.71 |
| 52 Week High | $13.66 | $108.00 |
Technical Indicators
Market Signals| Indicator | BAOS | SLRX |
|---|---|---|
| Relative Strength Index (RSI) | 45.52 | 24.12 |
| Support Level | $2.88 | $0.81 |
| Resistance Level | $3.80 | $0.90 |
| Average True Range (ATR) | 0.20 | 0.07 |
| MACD | -0.03 | 0.09 |
| Stochastic Oscillator | 6.06 | 9.82 |
Price Performance
Historical ComparisonAbout BAOS Baosheng Media Group Holdings
Baosheng Media Group Holdings Ltd operates as a V-log streaming marketing service provider. The firm offers comprehensive marketing solutions. Its services are Internet effect marketing, V-log or short video streaming marketing including content production and operation, e-commerce marketing, original data platform system service, and AI technology. It provides one-stop and full-link deep customized marketing solutions for partners. Baosheng Group is also a core agency of domestic Internet companies such as Tencent, Alibaba, Bytedance, and Kuaishou, with performing channel marketing services, technologies, and applications.
About SLRX Salarius Pharmaceuticals Inc.
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.